Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Acer Therapeutics Inc (ACER)

Acer Therapeutics Inc (ACER)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,634
  • Shares Outstanding, K 14,310
  • Annual Sales, $ 0 K
  • Annual Income, $ -22,890 K
  • 60-Month Beta 1.52
  • Price/Sales 7.77
  • Price/Cash Flow N/A
  • Price/Book 3.34
Trade ACER with:

Options Overview

Details
  • Implied Volatility 116.08%
  • Historical Volatility 78.57%
  • IV Percentile 15%
  • IV Rank 7.19%
  • IV High 869.45% on 09/10/20
  • IV Low 57.70% on 11/06/20
  • Put/Call Vol Ratio 0.23
  • Today's Volume 117
  • Volume Avg (30-Day) 88
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 1,205
  • Open Int (30-Day) 1,389

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.36
  • Number of Estimates 2
  • High Estimate -0.25
  • Low Estimate -0.46
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +35.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.28 +12.28%
on 07/20/21
3.10 -17.42%
on 07/29/21
-0.30 (-10.49%)
since 06/30/21
3-Month
2.28 +12.28%
on 07/20/21
3.14 -18.47%
on 06/11/21
-0.36 (-12.33%)
since 04/30/21
52-Week
2.15 +19.07%
on 09/11/20
5.84 -56.16%
on 08/07/20
-1.37 (-34.86%)
since 07/30/20

Most Recent Stories

More News
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy begins next week, July 13 - 15, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period...

ACOG.VN : 0.890 (-11.00%)
ACER : 2.56 (-8.57%)
ADXN : 9.85 (+8.24%)
AGRX : 1.2000 (-0.83%)
ATGN : 1.9500 (-1.02%)
ABIO : 3.16 (-7.33%)
AUUD : 3.23 (-2.12%)
BASA : 0.3648 (+1.33%)
BMRA : 3.75 (+3.31%)
BKTI : 3.23 (+0.94%)
BSFC : 6.0000 (+0.17%)
DTST : 4.02 (+0.50%)
DCTH : 10.20 (+3.24%)
DMIFF : 0.2356 (-0.76%)
DLPN : 7.84 (-1.75%)
FLUX : 9.93 (-1.19%)
GBNH : 11.50 (-2.71%)
HAVLF : 0.3103 (-6.96%)
ISDR : 27.96 (+1.01%)
INLB : 2.7088 (-1.50%)
KNWN : 2.9500 (-1.99%)
LXXGF : 0.4080 (+0.74%)
MKTY : 7.59 (+2.02%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0500 (+3.96%)
NEPH : 8.36 (-1.89%)
NMTC : 4.75 (+3.49%)
NLSP : 2.60 (-1.52%)
OBLG : 2.60 (-2.62%)
PBLA : 2.52 (-5.26%)
POSAF : 0.9363 (+11.36%)
PCSA : 5.98 (-5.38%)
PTIX : 2.16 (-3.14%)
QOEG : 0.1600 (-19.96%)
QIPT : 5.50 (-0.90%)
SNGX : 0.9530 (-2.76%)
STRR : 3.60 (-5.01%)
TGCB : 0.8900 (+15.58%)
VERB : 2.33 (-2.51%)
WTEQ.CN : 0.100 (unch)
WINT : 1.8900 (-1.05%)
AYRO : 4.40 (+0.23%)
BCTX : 5.08 (-7.47%)
BTX : 11.49 (-2.05%)
HWAL : 1.7700 (-3.80%)
NMRD : 7.58 (-0.39%)
THBRF : 3.3600 (-0.02%)
TRIQ : 1.6000 (+14.29%)
Savara (SVRA) Initiates Dosing in Pivotal Lung Disorder Study

Savara (SVRA) is developing its lead pipeline candidate, molgramostim, as a potential treatment for autoimmune pulmonary alveolar proteinosis.

CANF : 2.00 (-4.31%)
XNCR : 30.78 (-3.18%)
SVRA : 1.2800 (unch)
ACER : 2.56 (-8.57%)
Jazz Pharma (JAZZ) Gets FDA Approval for Leukemia Drug Rylaze

Jazz Pharma (JAZZ) gets FDA approval for Rylaze to treat acute lymphoblastic leukemia or lymphoblastic lymphoma with hypersensitivity to asparaginase.

JAZZ : 169.52 (-0.63%)
CANF : 2.00 (-4.31%)
XNCR : 30.78 (-3.18%)
ACER : 2.56 (-8.57%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified...

ACOG.VN : 0.890 (-11.00%)
ACER : 2.56 (-8.57%)
ADXN : 9.85 (+8.24%)
AGRX : 1.2000 (-0.83%)
ATGN : 1.9500 (-1.02%)
ABIO : 3.16 (-7.33%)
AUUD : 3.23 (-2.12%)
BASA : 0.3648 (+1.33%)
BKTI : 3.23 (+0.94%)
BSFC : 6.0000 (+0.17%)
DTST : 4.02 (+0.50%)
DCTH : 10.20 (+3.24%)
DMIFF : 0.2356 (-0.76%)
DLPN : 7.84 (-1.75%)
FLUX : 9.93 (-1.19%)
GBNH : 11.50 (-2.71%)
HAVLF : 0.3103 (-6.96%)
ISDR : 27.96 (+1.01%)
INLB : 2.7088 (-1.50%)
KNWN : 2.9500 (-1.99%)
LXXGF : 0.4080 (+0.74%)
MKTY : 7.59 (+2.02%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0500 (+3.96%)
NEPH : 8.36 (-1.89%)
NMTC : 4.75 (+3.49%)
NLSP : 2.60 (-1.52%)
OBLG : 2.60 (-2.62%)
PBLA : 2.52 (-5.26%)
POSAF : 0.9363 (+11.36%)
PCSA : 5.98 (-5.38%)
PTIX : 2.16 (-3.14%)
QOEG : 0.1600 (-19.96%)
QIPT : 5.50 (-0.90%)
SNGX : 0.9530 (-2.76%)
STRR : 3.60 (-5.01%)
TGCB : 0.8900 (+15.58%)
VERB : 2.33 (-2.51%)
WTEQ.CN : 0.100 (unch)
WINT : 1.8900 (-1.05%)
Zacks Industry Outlook Highlights: Xencor, Organogenesis Holdings, Cumberland Pharmaceuticals and Acer Therapeutics

Zacks Industry Outlook Highlights: Xencor, Organogenesis Holdings, Cumberland Pharmaceuticals and Acer Therapeutics

CPIX : 3.25 (-4.41%)
XNCR : 30.78 (-3.18%)
ACER : 2.56 (-8.57%)
ORGO : 15.34 (-0.45%)
What Makes Opexa Therapeutics, Inc. (ACER) a New Buy Stock

Opexa Therapeutics, Inc. (ACER) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ACER : 2.56 (-8.57%)
Thinking about buying stock in Acer Therapeutics, Cemtrex, Comstock Mining, Marker Therapeutics, or Strongbridge Biopharma?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACER, CETX, LODE, MRKR, and SBBP.

LODE : 3.21 (+2.88%)
MRKR : 2.09 (-1.42%)
SBBP : 2.39 (-3.63%)
ACER : 2.56 (-8.57%)
CETX : 1.2800 (-2.29%)
Thinking about buying stock in Check Cap, Shaw Comm., Acer Therapeutics, Intec Pharma, or GenMark Diagnostics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CHEK, SJR, ACER, NTEC, and GNMK.

GNMK : 24.04 (unch)
ACER : 2.56 (-8.57%)
CHEK : 1.1000 (-1.79%)
NTEC : 11.29 (-16.68%)
SJR : 29.18 (+0.14%)
Thinking about buying stock in Acer Therapeutics, Zomedica, Novan, Atossa Therapeutics, or Tellurian?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACER, ZOM, NOVN, ATOS, and TELL.

ZOM : 0.6084 (-0.26%)
NOVN : 7.88 (+5.35%)
ACER : 2.56 (-8.57%)
ATOS : 2.99 (-23.33%)
TELL : 3.77 (-5.28%)
Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease

RLFTF : 0.2570 (+6.20%)
ACER : 2.56 (-8.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Acer Therapeutics Inc. is a pharmaceutical company. It develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The company's product pipeline consists of Edsivo (TM) and ACER-001 which are in clinical stage. Acer Therapeutics Inc., formerly known as Opexa Therapeutics,...

See More

Key Turning Points

3rd Resistance Point 2.83
2nd Resistance Point 2.74
1st Resistance Point 2.65
Last Price 2.56
1st Support Level 2.47
2nd Support Level 2.38
3rd Support Level 2.29

See More

52-Week High 5.84
Fibonacci 61.8% 4.43
Fibonacci 50% 4.00
Fibonacci 38.2% 3.56
Last Price 2.56
52-Week Low 2.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar